Bruce Linton, current non-executive director of Auscann Group Holdings, has appointed David Pryce as his alternate director. Mr Pryce is vice president of international market expansion and global government relations at Canopy Growth Corporation, the largest cannabinoid medicine producer in North America. Auscann has also appointed Dr Danial Schecter, chief medical officer at Cannabinoid Medical Clinic in Toronto, as chief medical advisor.
Australia Asia Minerals has announced the appointments of current director Mark Baker as non-executive chair and Denis Reinhardt as non-executive director. Current non-executive director Chris Ritchie will become executive director.
Mission NewEnergy has advised of several retirements from the board in line with the current limited operations of the company. Non-executive directors Tan Sri Dato’ Seri Mohd Anwar bin Haji Mohd Nor and Mohd Azlan bin Mohammed, and non-executive chair Dato’ Mohamed Zain bin Mohamed Yusuf have retired from their roles. Current chief executive Dato’ Nathan Mahalingam will become executive chair.
